TREATING PRIMARY LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES, ARISING IN CENTRAL NERVOUS SYSTEM (PCNS-LBCL) AND VITREORETINAL (PVR-LBCL) BEYOND INDUCTION THERAPY: THE ROLE OF CONSOLIDATION AND MAINTENANCE THERAPY.
EHA Library, Maria Bouzani, 4162285
REAL WORLD OUTCOMES OF HISTONE DEACETYLASE INHIBITORS IN RELAPSED/ REFRACTORY PERIPHERAL T CELL LYMPHOMA: A MULTICENTRIC RETROSPECTIVE STUDY IN ARGENTINA
EHA Library, Laura Korin, 4162286
ROLE OF PET CT IN DETECTION OF BONE MARROW INFILTRATION IN PEDIATRIC MATURE B-CELL LYMPHOMA
EHA Library, Hani Abdel Rahman Sayed, 4162287
SOMETIMES OLD IS GOLD - DOES MINE RETAIN ITS GLEAM IN R/R DLBCL PATIENTS INELIGIBLE FOR ASCT?
EHA Library, Leonardo Maia Moço, 4162288
REAL-WORLD OUTCOMES OF PEDIATRIC T-CELL LYMPHOBLASTIC LYMPHOMA: EXTERNAL CONTROL COMPARISON OF CONVENTIONAL CHEMOTHERAPY VS. BORTEZOMIB-CONTAINING REGIMENS
EHA Library, Bo Kyung Kim, 4162289
BRENTUXIMAB VEDOTIN PLUS CHP-LIKE REGIMEN FOR THE FIRST-LINE TREATMENT OF PTCL PATIENTS: A REAL-WORLD SINGLE CENTER STUDY
EHA Library, Fang shu Guan, 4162291
THE EFFICACY AND SAFETY OF ORELABRUTINIB COMBINED WITH RITUXIMAB AND HIGH-DOSE METHOTREXATE IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY
EHA Library, Shujuan Wen, 4162292
TESTICULAR LYMPHOMA OF 63 PATIENTS: A CHINESE RETROSPECTIVE, REAL-WORLD STUDY
EHA Library, Xudong Zhang, 4162293
CLINICAL OUTCOMES COMPARISON BETWEEN TISAGENLECLEUCEL AND ALLOGENEIC HSCT FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: A DUAL-CENTER RETROSPECTIVE ANALYSIS
EHA Library, Youngwoo Jeon, 4162294
LONG-TERM FOLLOW-UP OF RESPONSE-DRIVEN DOSE-INTENSIFIED IMMUNOCHEMOTHERAPY ± AUTOLOGOUS STEM CELL TRANSPLANTATION IN PREVIOUSLY UNTREATED PATIENTS WITH HIGH-RISK AGGRESSIVE B-CELL LYMPHOMA: UPDATE FROM A SINGLE-CENTER EXPERIENCE
EHA Library, Ting Xie, 4162295
GEMCITABINE AND OXALIPLATIN +/- RITUXIMAB AS A SALVAGE REGIMEN IN RELAPSED OR REFRACTORY POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER: GUY'S HOSPITAL SINGLE-CENTRE EXPERIENCE
EHA Library, Craig Lennie, 4162296
A MULTICENTER, OPEN-LABEL, PHASE 3, RANDOMIZED TRIAL OF DUVELISIB VS INVESTIGATOR'S CHOICE (GEMCITABINE OR BENDAMUSTINE) IN RELAPSED/REFRACTORY NODAL T-CELL LYMPHOMA WITH T-FOLLICULAR HELPER PHENOTYPE
EHA Library, Kate Cwynarski, 4162297
EFFICACY AND SAFETY OF GLOFITAMAB COMBINED WITH TISLELIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A PILOT STUDY IN CHINA
EHA Library, De Zhou, 4162298
MULTIPLE INFUSIONS OF CART CELLS TREATMENT FOR HEMATOLOGIC MALIGNANT TUMOR(PH-B-ALL, DLBCL, MM)
EHA Library, Yihao Wang, 4162299
SELINEXOR IN COMBINATION WITH R-EPOCH FOR PATIENTS WITH PREVIOUSLY UNTREATED HIV-ASSOCIATED DLBCL: A SINGLE-CENTER, PROSPECTIVE, SINGLE-ARM TRIAL
EHA Library, Chaoyu Wang, 4162300
GOLIDOCITINIB COMBINED WITH CHOP IN NEWLY-DIAGNOSED PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL
EHA Library, Wei Zhang, 4162301
ORELABRUTINIB PLUS LENALIDOMIDE AND RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE-B CELL LYMPHOMA
EHA Library, Jie-Fei Bai, 4162302
CHECKPOINT INHIBITORS SHOW HIGH RESPONSE RATE IN RELAPSED OR REFRACTORY GRAY ZONE LYMPHOMAS
EHA Library, Ivan Dlouhy, 4162303
FIRST-LINE SELINEXOR IN COMBINATION WITH R-CHOP FOR EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (XPLORE): A SINGLE-ARM, PHASE IB/II TRIAL
EHA Library, Qingqing Cai, 4162304
EDUCATIONAL IMPACT OF LIVE AND ONLINE ENDURING CME/CE ON HEMATOLOGY/ONCOLOGY CARE TEAM SKILLS MANAGING LYMPHOMAS WITH BISPECIFIC ANTIBODIES: PRE-/POST- EDUCATION ASSESSMENT
EHA Library, Sarah Elizabeth Bomba, 4162305
HIGH-DOSE THIOTEPA COMBINED WITH RITUXIMAB AND POMALIDOMIDE IS A PERFECT ALTERNATIVE CHEMOTHERAPY REGIMEN FOR RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Xia Zhao, 4162306
THE IMPACT OF VOLUMETRIC MEASUREMENTS ASSESSED BY FDG-PET/CT ON SURVIVAL AND PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Esra Durmazer, 4162307
VALIDATION OF ESTABLISHED PROGNOSTIC SCORES AND INTEGRATION OF EASILY AVAILABLE BIOMARKERS IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA - A SINGLE-CENTER EXPERIENCE.
EHA Library, Greta Scapinello, 4162308
STUDY OF AUTOLOGOUS VS. ALLOGENEIC STEM CELL TRANSPLANTATION IN 56 PATIENTS WITH HIGH RISK EXTRANODAL NK/T -CELL LYMPHOMA
EHA Library, Haiwen Huang, 4162309
REAL-LIFE EXPERIENCE WITH MOGAMULIZUMAB IN PRIMARY CUTANEOUS T-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY
EHA Library, Antonio Giordano, 4162310
CLINICAL, ECONOMIC, AND HUMANISTIC OUTCOMES OF FIRST-LINE HIGH-RISK LARGE B-CELL LYMPHOMA: A SERIES OF SYSTEMATIC LITERATURE REVIEWS
EHA Library, Yi Lin, 4162311
TREATMENT OF PATIENTS WITH HISTIOCYTOSIS: RETROSPECTIVE MONOCENTRIC EXPERIENCE
EHA Library, Marianna Criscuolo, 4162312
ORAL LENALIDOMIDE OR BTK INHIBITORS AS MAINTENANCE THERAPY DEMONSTRATED DURABLE EFFICACY AFTER FIRST REMISSION IN PCNSL PATIENTS
EHA Library, Huiying Zhu, 4162313
CLINICAL AND RADIOLOGICAL PREDICTION MODELS FOR RANDOM SKIN BIOPSY POSITIVITY IN SUSPECTED INTRAVASCULAR LARGE B-CELL LYMPHOMA: DEVELOPMENT AND INTERNAL VALIDATION
EHA Library, Hajime Sakuma, 4162314
INFECTIOUS RISK OF RELAPSED/ REFRACTORY LYMPHOMA PATIENTS TREATED WITH CD3/CD20 BISPECIFIC ANTIBODIES - REAL WORLD DATA
EHA Library, Fernanda Seganfredo, 4162315
PROGNOSTIC ANALYSIS AND NOMOGRAM MODEL CONSTRUCTION FOR DIFFUSE LARGE B-CELL LYMPHOMA IN CHINESE ADOLESCENT AND YOUNG ADULT (AYA) POPULATION
EHA Library, Donghua He, 4162316
PET-CT-ADAPTED TREATMENT FOR EARLY-STAGE DIFFUSE LARGE B-CELL LYMPHOMA WITHOUT RISK FACTORS: PRELIMINARY ANALYSIS FROM THE GATLA GROUP
EHA Library, Fernando Warley, 4162317
IMPACT OF RELATIVE DOSE INTENSITY OF CHEMOTHERAPY IN ELDERLY PATIENTS WITH EXTRANODAL NK/T-CELL LYMPHOMA
EHA Library, Wanyue Zhao, 4162318
CLINICAL FEATURES AND PROGNOSTIC FACTORS OF INTRAVASCULAR LARGE B-CELL LYMPHOMA: A COHORT STUDY OF 20 PATIENTS FROM 2018 TO 2024
EHA Library, Mingzhi Zhang, 4162319
MYC STATUS IN DIFFUSE LARGE B-CELL AND AGGRESSIVE LYMPHOMA: TAKE INTO ACCOUNT REARRANGEMENTS BUT DON'T FORGET GAINS AND AMPLIFICATIONS
EHA Library, Sofia Garcia-Ferreiro, 4162320
CLINICAL FEATURES AND TREATMENT OUTCOMES OF HIV ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA: ANALYSIS OF THE THAI LYMPHOMA STUDY GROUP REGISTRY.
EHA Library, KANNADIT PRAYONGRATANA, 4162321
DOSE-REDUCED POLA-R-CHP FOR FRONTLINE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA IN ELDERLY AND COMORBID PATIENTS
EHA Library, Kunal Shah, 4162323
FIRST-LINE THERAPY OUTCOMES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: ? LARGE COHORT MULTICENTER STUDY
EHA Library, Vladislav Markelov, 4162324
POLATUZUMAB-R-CHP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA. A RETROSPECTIVE STUDY.
EHA Library, Alejandro Bobes, 4162325
AN ANALYSIS OF THE RELATIONSHIP OF TRIGLYCERIDE GLUCOSE INDEX WITH DIFFUSE LARGE B-CELL LYMPHOMA PROGNOSIS: A RETROSPECTIVE STUDY
EHA Library, QingQing Luo, 4162326
ZANUBRUTINIB MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-ARM PROSPECTIVE STUDY
EHA Library, yanli lai, 4162327
BGB-11417-302, A PHASE?3, RANDOMIZED, DOUBLE-BLIND STUDY OF SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS PLACEBO + ZANUBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
EHA Library, Marie Hughes, 4162328
GOLIDOCITINIB COMBINED WITH CHOP IN TREATMENT-NAÏVE MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM A PHASE 2 MULTICENTER, SINGLE-ARM GOAL STUDY
EHA Library, Li Wang, 4162329
CLINICAL IMPLICATIONS OF CEREBROSPINAL FLUID CTDNA AND INTERLEUKIN-10 IN PROGNOSIS PREDICTION AND DISEASE MONITORING FOR PRIMARY CENTRAL NERVOUS LYMPHOMA
EHA Library, Zhe Zhuang, 4162330
A NOVEL TREATMENT REGIMEN FOR NEWLY DIAGNOSED CAEBV INDUCING A HIGH RESPONSE RATE: PD-1 INHIBITOR, L-ASPARGASE AND CHIDAMIDE
EHA Library, Yi-ao Di, 4162331
STAGING BONE MARROW BIOPSIES AND INTERIM PET SCANS IN DLBCL: ESSENTIAL OR DISPENSABLE
EHA Library, Michael Caruana Dingli, 4162332
INCREASED TIGIT EXPRESSION CORRELATES WITH IMPAIRED NK CELL FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, hui lu, 4162333
EFFICACY AND SAFETY ANALYSIS OF ZANUBRUTINIB COMBINED WITH CHEMOTHERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, hongyun xing, 4162334
REAL-WORLD DATA OF AZACITIDINE FOR RELAPSED/REFRACTORY NODAL T-FOLLICULAR HELPER CELL LYMPHOMA IN 10 PATIENTS
EHA Library, Philipp Faustmann, 4162335
POLATUZUMAB VEDOTIN COMBINED WITH ORELABRUTINIB AND RITUXIMAB (PRO) DEMONSTRATES RAPID AND PROFOUND THERAPEUTIC EFFICACY IN TREATMENT-NAÏVE ELDERLY PATIENTS WITH NON-GERMINAL CENTER B-CELL (NON-GCB) OR GCB WITH MUM1+ DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, wenyu shi, 4162336
THE CMOP±R REGIMEN SHOWS HIGH EFFICACY AS A FIRST-LINE TREATMENT FOR NON-HODGKIN'S LYMPHOMA: A PHASE II CLINICAL TRIAL WITH MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON (MAIC) ANALYSIS
EHA Library, Tao You, 4162337
CHARACTERISTICS OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH RITUXIMAB INDUCED ACUTE THROMBOCYTOPENIA
EHA Library, Jianai Sun, 4162338
EFFICACY OF PEMETREXED-BASED REGIMENS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE-CENTER EXPERIENCE
EHA Library, Tarlan Kehtari, 4162339
OUTCOMES OF ZANUBRUTINIB COMBINED WITH POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-ZR-CHP) IN THE TREATMENT OF PATIENTS WITH EXTRANODAL (EN) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN A REAL-WORLD SETTING
EHA Library, Caixia Li, 4162340
PRIMARY BRAINSTEM LYMPHOMA: CLINICAL CHARACTERISTICS, TREATMENT METHODS, AND PROGNOSTIC FACTORS OF 56 PATIENTS
EHA Library, Wenhui Guo, 4162341
OUTCOMES AND SURVIVAL IN ELDERLY (≥60 YEARS) PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE-CENTER EXPERIENCE OF 186 PATIENTS
EHA Library, Kubilay Tay, 4162342
CHEMO-FREE REGIMENS CONTAINING GLOFITAMAB ARE SIGNIFICANTLY BENEFICIAL FOR RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH TP53 GENE MUTATIONS: REAL-WORLD DATA FROM MULTI-CENTERS IN CHINA
EHA Library, Xia Zhao, 4162344
THE ROLE OF INDUCTION RADIOTHERAPY AT A REDUCED DOSE FOLLOWED BY HIGH DOSE CHEMOTHERAPY IN CENTRAL NERVOUS SYSTEM LYMPHOMA: NEUROLOGIC SYMPTOMS CONTROL AND SURVIVAL BENEFIT
EHA Library, Maher Salamoon, 4162345
EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN COMBINED WITH MITOXANTRONE HYDROCHLORIDE LIPOSOME IN REFRACTORY/RELAPSED CD30+ PRIMARY CUTANEOUS OR CUTANEOUS-INFILTRATED T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS
EHA Library, Liufang Gu, 4162346
EFFICACY AND SAFETY OF ANTI-PD-1/PD-L1 ANTIBODIES IN PATIENTS WITH RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A META-ANALYSIS
EHA Library, Liang Wang, 4162347
EFFICACY AND SAFETY OF ZANUBRUTINIB IN COMBINATION WITH RITUXIMAB AND HIGH-DOSE METHOTREXATE FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B-CELL LYMPHOMA .
EHA Library, hongyun xing, 4162348
IMMUNE CHECKPOINT INHIBITORS IN AGGRESSIVE B-CELL LYMPHOMAS: A RETROSPECTIVE STUDY ON PATHOLOGICAL FEATURES, RESPONSE AND SURVIVAL
EHA Library, Rita Nader, 4162349
LATE RECURRENCE IN PEDIATRIC MATURE B CELL LYMPHOMA; CAUSES, PROGNOSIS AND TREATMENT OUTCOME
EHA Library, Hani Abdel Rahman Sayed, 4162350
EFFICACY AND SAFETY STUDY OF LINPERLISIB COMBINED WITH AZACITIDINE IN THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMA
EHA Library, hongyun xing, 4162351
ORELABRUTINIB PLUS R-CHOP-LIKE REGIMEN IN DOUBLE-EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD RETROSPECTIVE DATA
EHA Library, Lingke Zhang, 4162352
FIRST-LINE TREATMENT WITH POLATUZUMAB VEDOTIN IMPROVES EFFICACY AND SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE ANALYSIS
EHA Library, Jianxia He, 4162353
ANALYSIS OF GENETIC MUTATION PROFILE AND CNS PHARMACOKINETICS IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA PATIENTS RESPONDING TO NOVEL EMAVUSERTIB (IRAK4I) AND BTKI COMBINATION
EHA Library, Christian Grommes, 4162354
BETA-2 MICROGLOBULIN AS A PREDICTIVE MARKER FOR BULKY DISEASE IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Bahar Uncu Ulu, 4162355
IMMUNOSUPPRESSIVE AGENTS MAY BE A GOOD FRONT-LINE OPTION FOR THE TREATMENT OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA ASSOCIATED WITH HEMOPHAGOCYTIC SYNDROME
EHA Library, Jing Li, 4162356
REAL-WORLD ANALYSIS OF GLOFITAMAB IN RELAPSED/REFRACTORY B-CELL LYMPHOMA
EHA Library, Ping Yang, 4162357
EFFICACY OF ORELABRUTINIB COMBINED WITH R-CHOP(-LIKE) REGIMEN IN PREVIOUSLY UNTREATED DOUBLE-EXPRESSION (DE) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A SINGLE-CENTER REAL-WORLD ANALYSIS
EHA Library, Min Bai, 4162358
TRIAL IN PROGRESS: EPCORITAMAB WITH R-MINICVP FOR OLDER UNFIT/FRAIL OR ANTHRACYCLINE-INELIGIBLE ADULT PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Rahul Shah, 4162359
REAL EGYPTIAN SINGLE-CENTER EXPERIENCE IN MANTLE CELL LYMPHOMA DIAGNOSIS AND MANAGEMENT
EHA Library, Esraa Jamal, 4162360
COOLING IMMUNOCHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION MAY IMPROVE SURVIVAL IN PEDIATRIC SYSTEMIC EPSTEIN-BARR VIRUS-POSITIVE T-CELL LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
EHA Library, Bo Kyung Kim, 4162361
PREDICTIVE VALUE OF NK CELLS IN BONE MARROW FOR RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Sofia Rincon-Lopez, 4162362
INCIDENCE OF CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) OR HIGH-GRADE B-CELL LYMPHOMA (HGBCL) WITH CYTOGENETIC MYC ALTERATIONS
EHA Library, Esther Martinez Fresno, 4162363
PRIMARY EFFUSION LYMPHOMA: CASE SERIES AND A POTENTIAL PROGNOSTIC FACTOR
EHA Library, Juan Carlos Caballero, 4162364
HALP SCORE AND PRIMARY LYMPH NODE LOCALIZATION: ALTERNATIVE PROGNOSTIC PREDICTORS IN NON-HODGKIN LYMPHOMA WITH PRIMARY LYMPH NODE INVOLVEMENT
EHA Library, Victor Tomacinschii, 4162365
RETROSPECTIVE VALUATION AND LONG FOLLOW-UP OF SINGLE CENTRE EXPERIENCE FOR MAINTENANCE THERAPY WHIT RITUXIMAB PET ORIENTED AFTER INDUCTION WHIT R-CHOP IN AGGRESSIVE B NON HODGKIN LYMPHOMA.
EHA Library, MATTEO D'ADDONA, 4162366
POLA -R-CHP IN 1ST LINE TREATMENT DLBCL. KUWAIT CANCER CENTER EXPERIENCE
EHA Library, Rasha Abd El-Tawab Hamed, 4162367
THE NEW THERAPEUTIC APPROACHES IN ADVANCED STAGES OF MYCOSIS FUNGOIDES AND SEZARY SYNDROME
EHA Library, Liliya Gorenkova, 4162368
PEMETREXED AND ZANUBRUTINIB COMBINATION IN R/R CNS B-CELL LYMPHOMA: PRELIMINARY REPORT OF THE SAFETY LEAD-IN COHORT IN A SINGLE CENTER PHASE II STUDY
EHA Library, Yuliya Linhares, 4162369
GOLIDOCITINIB COMBINATION THERAPY AS FIRST-LINE TREATMENT IN PTCL: RETROSPECTIVE DATA FROM A SINGLE CENTRE
EHA Library, Wenyu Li, 4162370
HIGH GRADE B-CELL LYMPHOMA (HG-BL) WITH BLASTOID MORPHOLOGY - SUDDEN INCREASE IN INCIDENCE OF A RARE ENTITY
EHA Library, Neno Živković, 4162371
RESULTS OF THE USE OF PERSONALIZED IMMUNOCHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Katsiaryna Zharkova, 4162372
A REAL WORLD STUDY OF EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN ALONE OR IN COMBINATION WITH OTHER DRUGS IN RELAPSED REFRACTORY PERIPHERAL T CELL LYMPHOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Nia Siregar, 4162373
THE R-CHOP-LENALIDOMIDE-IBRUTINIB PROTOCOL IN THE TREATMENT OF ELDERLY PATIENTS WITHDIFFUSE B-CELL LARGE CELL LYMPHOMA, NOT OTHERWISE SPECIFIED.
EHA Library, Aminat Magomedova, 4162374
RESPONSE TO EPCORITAMAB CORRELATES WITH HIGHER ALC/AMC RATIO: INSIGHTS FROM A REAL-WORLD RETROSPECTIVE ANALYSIS
EHA Library, Yuwen Wang, 4162375
ONLINE EDUCATION ENHANCES PHYSICIAN MASTERY RELATED TO PATIENT-CENTERED CARE FOR DIFFUSE LARGE B-CELL LYMPHOMA AT FIRST RELAPSE
EHA Library, Victoria Harvey-Jones, 4162376
EFFICACY AND SAFETY OF SEQUENTIAL R-CDOP AND R-CMOP REGIMENS IN DLBCL PATIENTS WITH IPI SCORE 0-1 AND BULKY MASS: A RETROSPECTIVE ANALYSIS
EHA Library, Liufang Gu, 4162377
EFFICACY AND SAFETY OF EFBEMALENOGRASTIM ALFA IN THE TREATMENT OF NEUTROPENIA INDUCED BY RCHOP-LIKE REGIMENS IN NEWLY DIAGNOSED NON-HODGKIN'S LYMPHOMA PATIENTS: A RANDOMIZED CONTROLLED MULTICENTER CLINICAL STUDY
EHA Library, Jun Ma, 4162378
SHORT-TERM NEUROLOGICAL FUNCTIONAL RECOVERY AND TUMOR RESPONSE OF ZANUBRUTINIB, HIGH DOSE-METHOTREXATE AND RITUXIMAB IN TREATING NEWLY DIAGNOSED PCNSL PATIENTS WITH SEVERE IMPAIRMENT OF CONSCIOUSNESS
EHA Library, Hongqing Cai, 4162379
PD-1/CD20 DUAL-TARGET THERAPY IN UNFIT DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD PILOT STUDY
EHA Library, Jiesong Wang, 4162380
TRIAL IN PROGRESS : PHASE 2 TRIAL TO NB02 (POSELTINIB) COMBINED RITUXIMAB AND LENALIDOMIDE IN R/?R PCNSL (POTENTIAL-P)
EHA Library, Won Seog Kim, 4162381
POLA-R-CHP REGIMEN DEMONSTRATES HIGH EFFICACY AND MANAGEABLE SAFETY IN NEWLY DIAGNOSED PRIMARY GASTROINTESTINAL DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Xia Zhao, 4162382
PROGNOSTIC INDICES IN DIFFUSE LARGE B-CELL LYMPHOMA: IDENTIFYING THE BEST INDEX FOR FIRST RELAPSE ASSESSMENT
EHA Library, Catia Raquel Almeida Pais, 4162383
TREATMENT AND OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA : EXPERIENCE OF THE MILITARY HOSPITAL IN RABAT, MOROCCO
EHA Library, Asmae Azzouz, 4162384
ASSOCIATION OF CD47 EXPRESSION AND SYSTEMIC INFLAMMATION IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
EHA Library, Nia Siregar, 4162385
IDENTIFY NOVEL THERAPEUTIC TARGET FOR DLBCL PATIENTS: BASED ON SCRNA AND MENDELIAN RANDOMIZATION ANALYSIS
EHA Library, Fu Li, 4162386
EXPLORATION OF LOW-PASS WHOLE-GENOME SEQUENCING TECHNOLOGY BASED ON CTDNA FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Xudong Zhang, 4162387

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings